AzTrials
AzTrials

Smoking CessationSTOPNCT04263545

The Staff Stop Smoking Project

A study testing Group session with smoking cessation counsellor in people with Smoking Cessation, run by Portsmouth Hospitals NHS Trust at 2 sites in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Participants will be randomised to either standard care or to receive our help to quit programme. The study will only be available to Portsmouth Hospital Trust staff member. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Smoking Cessation
What is being tested?
Group session with smoking cessation counsellor
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
30 participants
Where
2 sitesUnited Kingdom
Study dates
3 Jun 2019to 21 Jun 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Male or Female, aged 18 years or over
  • Willing and able to give informed consent for participation in the study.
  • Must work for PHT at QAH and be able to attend weekly meetings for the duration of the study period
  • Must be a current smoker

Who cannot join

  • -Unable to comprehend the study and provide informed consent e.g. insufficient command of English in the absence of someone to adequately interpret.

Trial locations and contacts

2 sites in 1 country.

United Kingdom2 sites
  • Portsmouth Hospitals NHS Trust, Queen Alexandra Hospital

    Portsmouth, Hampshire, PO6 3LY

  • Portsmouth Hospitals NHS Trust

    Portsmouth, PO6 3LY

Other trials in United Kingdom

About this study

Official title: A Randomised Feasibility Study Comparing a Novel Intervention for Smoking Cessation in NHS Staff to Standard Care

Participants will be randomised to either standard care or to receive our help to quit programme. The study will only be available to Portsmouth Hospital Trust staff member.

Read the detailed description

A randomised controlled feasibility study to trial a novel intervention to help NHS staff stop smoking compared to standard care. Participants will attend one-on-one interviews and a support group where they will undertake CO monitoring and mini-spirometry. They will complete questionnaires about their quality of life, other health problems and their general state of health. They will attend the support groups on a weekly basis and have access to support outside of these times.

Being tested
Group session with smoking cessation counsellor, Standard Care
Medical subject headings
Smoking Cessation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Group session with smoking cessation counsellorBehavioural

    Group session with smoking cessation counsellor

  • Standard CareBehavioural

    standard care arm will receive very brief advice (VBA) and signposting to local organisations to support a quit.

Study groups in NCT04263545
Study groupRoleWhat they receive
InterventionActive comparatorNot described
Receives: Behavioral: Group session with smoking cessation counsellor
Standard CarePlacebo comparatorNot described
Receives: Behavioral: Standard Care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Behavioural outcomes

    Number of smokers who achieve a successful quit

    Measured: 4 weeks

  2. Behavioural outcomes

    Number of smokers who achieve a successful quit

    Measured: 12 weeks

  3. Behavioural outcomes

    Number of smokers who achieve a successful quit

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Feb 2020
  2. Study start3 Jun 2019
  3. Primary completion21 Jun 2019
  4. Study completion21 Jun 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
meeting with a smoking cessation counsellor to discuss their individual requirements for smoking cessation and be offered their choice of pharmacological intervention. They will be provided with their choice of pharmacotherapy on site.They will then be invited to attend a group session, where they will have some brief lung function tests and check carbon monoxide levels. Participants will be offered refreshments and receive a bespoke group session to address various aspects of smoking cessation.
Masking
None (open label)
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04263545
Sponsor's protocol ID
PHT/2019/17
Acronym
STOP
Status last verified
Jan 2020
First submitted
29 Jan 2020
Last updated
10 Feb 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Group session with smoking cessation counsellor in people with Smoking Cessation, run by Portsmouth Hospitals NHS Trust at 2 sites in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Feb 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Behavioural outcomes (time frame: 4 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Feb 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in